The combination of once-weekly cagrilintide 2.4 mg and semaglutide 2.4 mg conferred greater weight loss at 68 weeks compared ...

Chen, who has kept his “overweight” call on REITs, notes that Singapore, as a long-standing and strategic partner of the US, ...

While some food processing is beneficial – such as pasteurising milk to kill bacteria – the ones that cause parents concern ...

The colours that overweight men and women usually wear are the same. For a sleek and stylish fit, one needs to pick the right ...

CHICAGO -- Adding investigational cagrilintide to a GLP-1 receptor agonist increased weight loss in adults with obesity with ...

Adults with overweight or obesity who received once-weekly ecnoglutide, a novel GLP-1 receptor agonist, had superior and ...

(Reuters) -Novo Nordisk on Sunday said full results from two late-stage trials of its experimental weight-loss drug CagriSema ...

A recent study reveals a concerning trend. Many Indian households have all adults overweight or obese. ICMR-NICPR researchers ...

Many people believe that being overweight always leads to type 2 diabetes, but the truth is more complicated. While being ...

More than 90% of patients achieved clinically meaningful weight reduction compared to placebo in a phase 3 trial of ecnoglutide.

A novel weight loss drug in the same class as semaglutide has successfully met its targets in its largest clinical trial yet, ...